FDA
-
-
-
-
-
-
-
Charles River to acquire two companies for $570 million total
-
-
-
-
-
-
-
Charles River names interim CFO after Pease resignation
-
-
-
-
-
-
-
Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development
-
-
-
-
-
-
-
Charles River Introduces Global Biotech Incubator Program
-
-
-
-
-
-
-
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
-
-
-
-
-
-
-
Charles River Laboratories Announces Second-Quarter 2023 Results
-
-
-
-
-
-
-
Charles River and Rznomics Announce RNA-based Anticancer Gene Therapy Manufacturing Alliance
-
322,199 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

